Clinical Trials Logo

Filter by:
NCT ID: NCT04318860 Completed - Postoperative Pain Clinical Trials

Postoperative Pain After Colorectal Surgery

Start date: March 15, 2013
Phase:
Study type: Observational

This study aimed to evaluate pain after elective colorectal surgery and to identify risk factors for postoperative pain. Patients:All elective colorectal surgeries at the department of surgery, Umeå university Hospital, Umeå, Sweden from March 2013 to April 2017 Primary outcome:The primary outcome measurement is the numeric rating scale (NRS), graded from 0-10, on day of surgery, postoperative (POD) 1, 2, 3. The patients are questioned by nurses each morning on four postoperative days to score the maximum pain during the previous 24 hours using the NRS.

NCT ID: NCT04317716 Completed - Multiple Sclerosis Clinical Trials

A Self-management Program to Prevent Falls in People With Multiple Sclerosis

Start date: February 11, 2022
Phase: N/A
Study type: Interventional

This project's overall aim is to develop, deliver, and evaluate feasibility of a fall prevention program for ambulatory and non-ambulatory people with multiple sclerosis. The program will use a comprehensive intervention approach to address a variety of fall risk factors, and utilise self-management strategies. Specific aims are to 1. develop a fall prevention program, that addresses diverse fall risk factors and utilises self-management strategies, for ambulatory and non-ambulatory people with multiple sclerosis using a co-design process. 2. To examine feasibility, acceptability, fidelity, and potential outcome of the online, co-designed self-management fall prevention intervention for ambulatory and non-ambulatory people with multiple sclerosis, and to examine feasibility of the recruitment process, the data collection procedures, and the outcome measures.

NCT ID: NCT04317612 Completed - Memory Impairment Clinical Trials

Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment

MINDBERRY
Start date: June 3, 2020
Phase: N/A
Study type: Interventional

The aim of the current study is to investigate whether daily intake of Nordic berries for 12 weeks can improve cognitive abilities of adults with mild cognitive impairment, and whether the effect can be linked to changes in metabolic parameters.

NCT ID: NCT04314427 Completed - Clinical trials for Diabetes Mellitus Type 2 in Obese

Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS

Start date: September 2012
Phase:
Study type: Observational

Describe and characterize the time-course for improvement in glucose control after bariatric surgery in obese patients with type 2 diabetes Compare these changes in glycemic control after different techniques for bariatric surgery

NCT ID: NCT04313439 Completed - Clinical trials for Obsessive-Compulsive Disorder

Targeting Taboo Thoughts In Obsessive-Compulsive Disorder

Start date: March 26, 2020
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to investigate if a cognitive treatment targeting obsessive beliefs in patients with aggressive obsessions is feasible and effective as an online treatment.

NCT ID: NCT04312386 Completed - Food Habits Clinical Trials

Fostering Healthy and Sustainable Diets Through School Meals (OPTIMAT Uppsala)

OPTIMAT-U
Start date: January 20, 2020
Phase: N/A
Study type: Interventional

School meals have considerable potential to shape children's diets and reduce the climate impact of meals. This study applies linear programming for developing and implementing a climate friendly, nutritious and affordable school lunch menu. The new menu plan will be compared to the baseline menu during a 4-week intervention trial. The outcomes will be food waste, consumption, and pupils' satisfaction with the meals before and after introducing the new meal plan analyzed by interrupted time series analysis. Our hypothesis is that school meals can be optimized to be nutritious and more climate friendly, without negatively affecting acceptance, food waste and cost. Four primary schools in one Swedish municipality with the same menu plan for all schools will participate in the study. Their current meal supply will be recorded in the form of a food list including amount and cost of each item over a 4-week period. This list will then be optimized with linear programming to be as similar as possible to the baseline diet but with a reduction in greenhouse gas emissions of about 30%. No new foods will be introduced and none will be removed from the list. Nutritionally adequacy will be ensured by including constraints into the model. The optimized food list will be handed to the municipality's meal planner and a new menu plan will be developed based on the revised food list. Data on food waste and consumption will be collected daily during a baseline period of four weeks, and during the four-week intervention period. School lunch satisfaction will be assessed twice with an online questionnaire at baseline and during the intervention.

NCT ID: NCT04307225 Completed - Stroke Clinical Trials

Atrial Fibrillation After CABG and PCI

AFAF
Start date: August 2015
Phase:
Study type: Observational [Patient Registry]

Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice and is associated with an increased risk of stroke, heart failure and death. Oral anticoagulation (OAC) is the only treatment so far being able to reduce mortality in AF patients, despite new antiarrhythmic drugs and ablation techniques. Postoperative AF affects one-third of patients undergoing aortocoronary bypass surgery (CABG). Postoperative AF is associated with an increased 30-day mortality compared to patients who are in sinus rhythm during the hospital stay. . The risk of future AF is increased in patients with postoperative AF, and one-fourth of patients with an episode of postoperative AF develop later AF. At six years follow-up, 9.1% of patients with postoperative AF have had a lethal or non-lethal episode of ischemic stroke, compared to 3.0% of patients in SR (p=.002). Atrial fibrillation is a common complication of myocardial infarction, with an incidence of new-onset AF between 5-20%. New-onset AF occurs postoperatively in 5-6% of patients undergoing acute percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), and is marker of adverse outcomes. However, studies of heart rhythm beyond the post procedural period following PCI are lacking. About one third of all AF is asymptomatic, silent and often paroxysmal. The risk of stroke seems to be the same for silent AF as for those with symptomatic AF. In trials comparing PCI and CABG, there is a consistent difference in stroke rate. Several studies have shown an increased risk of late cardiovascular death and ischemic stroke in postoperative AF patients, and the difference in stroke rate between PCI and CABG may be explained by unprotected episodes of AF after discharge. The investigators therefore hypothesize that patients undergoing CABG have an increased risk of silent AF postoperatively compared to patients undergoing PCI and that this difference may explain some of the differences in stroke rate between PCI and CABG patients.

NCT ID: NCT04306809 Completed - Chronic Pain Clinical Trials

iACT for PTSD and Chronic Pain : a Development Pilot Series

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy for PTSD and comorbid chronic pain. First, a pilot study (no randomization; N=10) will be conducted to test the intervention and assessment procedures. This will be followed by a randomized controlled trial with waitlist control. The participants will go through an active internet-based ACT treatment focused on education about PTSD, value-based exposure for the traumatic memory and avoided situations, and behavior change through exercises targeting the processes mindfulness, cognitive defusion and acceptance. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 3 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.

NCT ID: NCT04306393 Completed - Coronavirus Clinical Trials

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19

NOSARSCOVID
Start date: March 21, 2020
Phase: Phase 2
Study type: Interventional

Severe acute respiratory syndrome (SARS-CoV2) due to novel Coronavirus (2019-nCoV) related infection (COVID-19) is characterized by severe ventilation perfusion mismatch leading to refractory hypoxemia. To date, there is no specific treatment available for 2019-nCoV. Nitric oxide is a selective pulmonary vasodilator gas used in as a rescue therapy in refractory hypoxemia due to acute respiratory distress syndrome (ARDS). In-vitro and clinical evidence indicate that inhaled nitric oxide gas (iNO) has also antiviral activity against other strains of coronavirus. The primary aim of this study is to determine whether inhaled NO improves oxygenation in patients with hypoxic SARS-CoV2. This is a multicenter single-blinded randomized controlled trial with 1:1 individual allocation

NCT ID: NCT04304937 Completed - Quality of Life Clinical Trials

Validation of Swedish Short PROM för Venous Insufficiency

Start date: January 1, 2018
Phase:
Study type: Observational

Validation of a new short Swedish patient reported outcome measure for superficial venous insufficiency. Analysis of its capacity to measure quality of life and its responsiveness to change caused by treatment.